Your browser doesn't support javascript.
Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection.
Sui, Zhiwei; Dai, Xinhua; Lu, Qingbin; Zhang, Yulan; Huang, Min; Li, Shufen; Peng, Tao; Xie, Jie; Zhang, Yongzhuo; Wu, Chunchen; Xia, Jianbo; Dong, Lianhua; Yang, Jiayi; Huang, Wenfeng; Liu, Siyuan; Wang, Ziquan; Li, Ke; Yang, Qingfang; Zhou, Xi; Wu, Ying; Liu, Wei; Fang, Xiang; Peng, Ke.
  • Sui Z; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Dai X; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Lu Q; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.
  • Zhang Y; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Huang M; Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Wuhan, China.
  • Li S; Department of Laboratory Medicine, Huazhong University of Science and Technology, Tongji Hospital, Tongji Medical College, HUST, Wuhan, Hubei, China.
  • Peng T; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Xie J; Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Wuhan, China.
  • Zhang Y; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Wu C; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Xia J; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Dong L; Department of Laboratory Medicine, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yang J; Department of Laboratory Medicine, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang W; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Liu S; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Wang Z; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Li K; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Yang Q; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
  • Zhou X; Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
  • Wu Y; Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
  • Liu W; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Fang X; Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Wuhan, China.
  • Peng K; University of Chinese Academy of Sciences, Beijing, China.
Signal Transduct Target Ther ; 6(1): 181, 2021 05 10.
Article in English | MEDLINE | ID: covidwho-1223081
ABSTRACT
Over 40% of the coronavirus disease 2019 (COVID-19) COVID-19 patients were asymptomatically infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the immune responses of these asymptomatic individuals is a critical factor for developing the strategy to contain the COVID-19 pandemic. Here, we determined the viral dynamics and antibody responses among 143 asymptomatic individuals identified in a massive screening of more than 5 million people in eight districts of Wuhan in May 2020. Asymptomatic individuals were admitted to the government-designated centralized sites in accordance with policy. The incidence rate of asymptomatic infection is ~2.92/100,000. These individuals had low viral copy numbers (peaked at 315 copies/mL) and short-lived antibody responses with the estimated diminish time of 69 days. The antibody responses in individuals with persistent SARS-CoV-2 infection is much longer with the estimated diminish time of 257 days. These results imply that the immune responses in the asymptomatic individuals are not potent enough for preventing SARS-CoV-2 re-infection, which has recently been reported in recovered COVID-19 patients. This casts doubt on the efficacy of forming "herd-immunity" through natural SARS-CoV-2 infection and urges for the development of safe and effective vaccines.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 / Immunity / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00596-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 / Immunity / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00596-2